Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
5445391
Reference Type
Journal Article
Title
GLC Determination of Plasma Concentrations of γ-OxO Metabolite of Phenylbutazone
Author(s)
Midha, KK; Mcgilveray, IJ; Cooper, JK
Year
1978
Is Peer Reviewed?
Yes
Journal
Journal of Pharmaceutical Sciences
ISSN:
0022-3549
EISSN:
1520-6017
Volume
67
Issue
2
Page Numbers
279-281
Language
English
PMID
621659
DOI
10.1002/jps.2600670246
URL
http://www.sciencedirect.com/science/article/pii/S0022354915398208
Exit
Abstract
A quantitative method for the γ-OxO metabolite of phenylbutazone from plasma is described. The procedure involved an ethylene dichloride extraction of acidified plasma to which an internal standard, acenocoumarol, had been added. The extracted γ-OxO metabolite and the internal standard were methylated and analyzed by GLC. Determination of 0.25μg of γ-OxO metabolite/ml with a relative standard deviation of 6.5% was accomplished.
Keywords
Phenylbutazone γ-OxO metabolite—GLC analysis in plasma; Metabolites—γ-OxO derivative of phenylbutazone; γ-OxO metabolite of phenylbutazone—GLC analysis in plasma; GLC—analysis; Antirheumatic agents—phenylbutazone
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity